01
肺隐球菌病的
临床特点

图1 无免疫抑制的肺隐球菌病患者的胸部CT[3]

图2 [4]
02
诊断方法和“金标准”
03
药物治疗[3]
表1 肺隐球菌病用药方案

04
实例解析

图3
参考来源:
[1]Kuroki K, Phichaichumpon C, Yasuoka A, Chiranairadul P, Chosa T, Sirinirund P, et al. Environmental isolation of Cryptococcus neoformans from an endemic region of HIV-associated cryptococcosis in Thailand.Yeast 2004;21:809-12.
[2]Nakamura S, Miyazaki Y, Higashiyama Y, Yanagihara K, Ohno H, Hirakata Y, Shikuwa M, Mizuta Y, Tashiro T, Kohno S. Community acquired pneumonia (CAP) caused by Cryptococcus neoformans in a healthy individual. Scand J Infect Dis. 2005;37(11-12):932-5.
[3]浙江省医学会呼吸病学分会. 肺隐球菌病诊治浙江省专家共识[J]. 中华临床感染病杂志, 2017, 10(5):6.
[4]Shankar EM, Kumarasamy N, Bella D, Renuka S, Kownhar H, Suniti S, Rajan R, Rao UA. Pneumonia and pleural effusion due to Cryptococcus laurentii in a clinically proven case of AIDS. Can Respir J. 2006 Jul-Aug;13(5):275-8.
[5]Singh N, Alexander BD, Lortholary O, et al. Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen. Clin Infect Dis. 2008 Jan 15;46(2):e12-8.
[6]浙江省医学会热带病和寄生虫病分会艾滋病学组. 艾滋病患者隐球菌感染筛查浙江省专家共识[J]. 中华临床感染病杂志, 2019, 12(2):7.
[7]Cheon WS, Eom KS, Yoo BK, Jang SH, Bahn JW, Kim DG, Jung KS. A case of pulmonary cryptococcosis by capsule-deficient Cryptococcus neoformans. Korean J Intern Med. 2006 Mar;21(1):83-7.
